Therini Bio raises nearly $40M to study DME and Alzheimer's immunotherapeutics
Business

Therini Bio raises nearly $40M to study DME and Alzheimer's immunotherapeutics

Funding to support two trials on fibrin-targeting immunotherapies targeting vascular dysfunction-induced neuroinflammation in severe retinal and neurological diseases.
Viridian reports long-term durability data, secures FDA designation for TED therapy
Pipeline

Viridian reports long-term durability data, secures FDA designation for TED therapy

After receiving FDA Breakthrough Therapy designation, new 52-week data finds 70% of proptosis responders at Week 15 maintained their response.
Researchers identify risk factors for unplanned OR visits post-cataract surgery
Research

Researchers identify risk factors for unplanned OR visits post-cataract surgery

Study reports tamsulosin use as one of two key risk factors for postoperative complications.
FDA approves Genentech's Susvimo for DR
Products

FDA approves Genentech's Susvimo for DR

First sustained-release delivery system of ranibizumab earns third indication, with injections needed just once every 9 months.
FDA clears Selagine's immunoglobulin DED drops for phase 2 trial
Pipeline

FDA clears Selagine's immunoglobulin DED drops for phase 2 trial

IND approval supports clinical development and evaluation of the anti-inflammatory and immunomodulatory biologic drug, potentially the first of its kind in the U.S.
Bausch + Lomb launches PF LUMIFY redness reliever drops
Products

Bausch + Lomb launches PF LUMIFY redness reliever drops

Newest preservative-free, OTC formulation of low-dose brimonidine tartrate is available in single-use vials to relieve eye redness due to minor ocular irritations.
Topcon invests in MedTech startup’s microdosing drug delivery system
Business

Topcon invests in MedTech startup’s microdosing drug delivery system

Collaboration involves MistGo Digital, under clinical development as a drug delivery system combined with a digital adherence monitoring platform.
ADHD medication may lead to corneal cell changes in pediatric patients
Research

ADHD medication may lead to corneal cell changes in pediatric patients

Study notes differences in key parameters of corneal and retinal health in patients taking methylphenidate.
FDA OKs clinical trial on Atia Vision's novel IOL for cataract patients
Pipeline

FDA OKs clinical trial on Atia Vision's novel IOL for cataract patients

IDE approval brings company one step closer toward seeking regulatory clearance for the OmniVu Lens System, a dual-optic IOL.
Atsena releases favorable LIGHTHOUSE trial data on XLRS gene therapy
Pipeline

Atsena releases favorable LIGHTHOUSE trial data on XLRS gene therapy

Positive findings from 1-year post-treatment show meaningful improvements on visual function measurements, with foveal schisis closure observed in 67% of patients.
Air pollution exposure leading to more ocular disease cases among adults
Research

Air pollution exposure leading to more ocular disease cases among adults

Myopic eyes demonstrated increased risk of ocular disease with exposure to air pollution.
New alliance seeks a shift in healthcare via AI-based oculomics
Research

New alliance seeks a shift in healthcare via AI-based oculomics

Healthcare leader-led consortium Alliance for Healthcare from the Eye calls for a proactive healthcare approach, with a focus on prescreenings for ocular and systemic health.
Allotex names new CEO to lead commercialization of allogeneic corneal tissue technology
Business

Allotex names new CEO to lead commercialization of allogeneic corneal tissue technology

Co-founder Michael Mrochen, PhD, will assume leadership as the startup seeks an IDE for its biocompatible procedure for vision correction.
Nicox releases favorable phase 3b data on IOP-lowering glaucoma therapeutic
Pipeline

Nicox releases favorable phase 3b data on IOP-lowering glaucoma therapeutic

Exploratory Whistler trial reports statistically significant IOP lowering and uveoscleral outflow for NCX 470, an NO-donating bimatoprost formulation.
How safe are iPSC-based RPE strip transplants for patients with RPE degeneration?
Research

How safe are iPSC-based RPE strip transplants for patients with RPE degeneration?

First clinical report of allogeneic iPSC-derived RPE strip transplantation demonstrated success in all three patients.
B+L launches Zenlens CHROMA HOA scleral contact lenses
Products

B+L launches Zenlens CHROMA HOA scleral contact lenses

Newest addition to the scleral lens brand features a custom-designed, wavefront-guided scleral lens technology intended to correct advanced HOA.
New data supports Hoya's DIMS lenses for myopic prevention among preschool-aged pediatrics
Research

New data supports Hoya's DIMS lenses for myopic prevention among preschool-aged pediatrics

Presented at ARVO, updated findings among the younger pre-myopics confirmed a protective effect of the patented and embedded technology on refractive status.
New World Medical launches upgraded Streamline Surgical System
Products

New World Medical launches upgraded Streamline Surgical System

Single-use, implant-free device offers surgeons improved visualization of key anatomical structures via a new transparent tip.
Zeiss debuts new research data platform for integrated workflows
Products

Zeiss debuts new research data platform for integrated workflows

Company’s cloud-based solution uses AI technology to integrate accessible clinical and research data into clinicians’ daily routines.
Optic neuritis is on the rise among specific patient demographics
Research

Optic neuritis is on the rise among specific patient demographics

Study addresses a paucity of data on the prevalence of optic neuritis in the US.